Literature DB >> 2304143

Protein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeat.

H T Poteat1, F Y Chen, P Kadison, J G Sodroski, W A Haseltine.   

Abstract

The long terminal repeat (LTR) of the human T-cell leukemia virus type I (HTLV-I) contains an imperfect repeat of 21 nucleotides which governs the response to the virus trans-activator protein tax and to cyclic AMP. In a murine thymocyte cell line defective in the catalytic subunit of protein kinase A, the response of the HTLV-I LTR to cyclic AMP is abolished and the response to tax is substantially diminished. This report shows that a factor present in nuclear extracts of wild-type cells binds to the HTLV-I 21-nucleotide sequence and that this binding activity is missing from the extracts of protein kinase A-defective cells. Treatment of nuclear extracts of protein kinase A-defective cells with the bovine protein kinase A catalytic subunit restores the binding activity, whereas treatment of wild-type nuclear extracts with a protein phosphatase destroys the binding activity. The binding factor is referred to as protein kinase A-dependent factor (PKAF). These results indicate that in murine thymocytes the response of the HTLV-I LTR to cyclic AMP depends upon the binding of a phosphorylated protein to the 21-nucleotide repeat sequence and that the response to tax is partially dependent upon binding of the phosphorylated protein. The results suggest a model in which the phosphorylation of a transcription factor by protein kinase A regulates HTLV-I gene expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304143      PMCID: PMC249242     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Molecular mechanisms of cyclic AMP action: a genetic approach.

Authors:  P Coffino; H R Bourne; U Friedrich; J Hochman; P A Insel; I Lemaire; K L Melmon; G M Tomkins
Journal:  Recent Prog Horm Res       Date:  1976

2.  In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.

Authors:  F Shirakawa; S B Mizel
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

3.  Purification and characterization of multiple nuclear factors that bind to the TAX-inducible enhancer within the human T-cell leukemia virus type 1 long terminal repeat.

Authors:  T H Tan; M Horikoshi; R G Roeder
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

Review 4.  Modulation of inflammation and immunity by cyclic AMP.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon; C S Henney; Y Weinstein; G M Shearer
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

Review 5.  The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response.

Authors:  G M Kammer
Journal:  Immunol Today       Date:  1988 Jul-Aug

6.  Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth.

Authors:  P A Insel; H R Bourne; P Coffino; G M Tomkins
Journal:  Science       Date:  1975-11-28       Impact factor: 47.728

7.  U3 sequences from HTLV-I and -II LTRs confer pX protein response to a murine leukemia virus LTR.

Authors:  H Kitado; I S Chen; N P Shah; A J Cann; K Shimotohno; H Fan
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

8.  A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements.

Authors:  J Fujisawa; M Toita; M Yoshida
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

9.  Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector.

Authors:  R Grassmann; C Dengler; I Müller-Fleckenstein; B Fleckenstein; K McGuire; M C Dokhelar; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Bovine leukemia virus trans-activator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF.

Authors:  I Katoh; Y Yoshinaka; Y Ikawa
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  14 in total

1.  Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer.

Authors:  L J Zhao; C Z Giam
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Role of protein kinase C and 72 kDa heat shock protein in ischemic tolerance following heat stress in the rat heart.

Authors:  R C Kukreja; Y Z Qian; S Okubo; E E Flaherty
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 3.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

4.  In vitro activation of transcription by the human T-cell leukemia virus type I Tax protein.

Authors:  M A Matthews; R B Markowitz; W S Dynan
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

5.  Role of protein kinase A in tax transactivation of the human T-cell leukemia virus type I long terminal repeat.

Authors:  P Kadison; H T Poteat; K M Klein; D V Faller
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction.

Authors:  L J Zhao; C Z Giam
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  GLI-2 modulates retroviral gene expression.

Authors:  M J Smith; S D Gitlin; C M Browning; B R Lane; N M Clark; N Shah; S Rainier; D M Markovitz
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Identification and functional characterisation of the cellular activating transcription factor 43 (ATF-43) protein.

Authors:  H C Hurst; N F Totty; N C Jones
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

9.  Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.

Authors:  N M Clark; M J Smith; J M Hilfinger; D M Markovitz
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Multistep regulation of enhancer activity of the 21-base-pair element of human T-cell leukemia virus type I.

Authors:  M Niki; K Ohtani; M Nakamura; K Sugamura
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.